10.96
-0.04 (-0.36%)
| Previous Close | 11.00 |
| Open | 10.85 |
| Volume | 13,821 |
| Avg. Volume (3M) | 58,350 |
| Market Cap | 167,905,008 |
| Price / Sales | 0.460 |
| Price / Book | 0.430 |
| 52 Weeks Range | |
| Earnings Date | 12 Feb 2025 - 17 Feb 2025 |
| Profit Margin | -59.13% |
| Operating Margin (TTM) | -40.32% |
| Diluted EPS (TTM) | -10.13 |
| Quarterly Revenue Growth (YOY) | 12.30% |
| Total Debt/Equity (MRQ) | 2.39% |
| Current Ratio (MRQ) | 2.92 |
| Operating Cash Flow (TTM) | -92.69 M |
| Levered Free Cash Flow (TTM) | -21.27 M |
| Return on Assets (TTM) | -20.31% |
| Return on Equity (TTM) | -43.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | American Well Corporation | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -5.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -1.88 |
|
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 5.35% |
| % Held by Institutions | 46.84% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Alerce Investment Management, L.P. | 30 Sep 2024 | 523,785 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 9.00 (UBS, -17.88%) | Hold |
| Median | 8.00 (-27.01%) | |
| Low | 7.50 (Truist Securities, -31.57%) | Hold |
| Average | 8.13 (-25.82%) | |
| Total | 4 Hold | |
| Avg. Price @ Call | 7.26 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 23 May 2025 | 8.00 (-27.01%) | Hold | 7.42 |
| UBS | 08 May 2025 | 9.00 (-17.88%) | Hold | 6.96 |
| Stifel | 02 May 2025 | 8.00 (-27.01%) | Hold | 7.41 |
| Truist Securities | 10 Apr 2025 | 7.50 (-31.57%) | Hold | 7.25 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 May 2025 | Announcement | Amwell makes grant to new employee under inducement plan |
| 01 May 2025 | Announcement | Amwell® Announces Results for First Quarter 2025 |
| 24 Apr 2025 | Announcement | Amwell® to participate in upcoming investor conferences |
| 17 Apr 2025 | Announcement | Amwell® to report first quarter 2025 operating results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |